SCHEDULE 13D/A: Major Shareholder Elray Resources Converts Preferred Stock, Boosting Stake in 180 Life Sciences to Over 50%

Elray Resources, Inc., a significant shareholder in 180 Life Sciences Corp., converted 1 million shares of Series B Convertible Preferred Stock into 1.318 million common shares, increasing its beneficial ownership to 52.8% of the company's outstanding common stock.

Summary

• This document is Amendment No. 1 to a Schedule 13D filing by Anthony Brian Goodman and Elray Resources, Inc. regarding their ownership in 180 LIFE SCIENCES CORP.
• On March 27, 2025, Elray Resources, Inc. converted 1,000,000 shares of Series B Convertible Preferred Stock into 1,318,000 shares of Common Stock of 180 Life Sciences Corp., in accordance with the terms of the preferred stock.
• Following this conversion, Anthony Brian Goodman and Elray Resources, Inc. beneficially own an aggregate of 4,318,000 shares of Common Stock.
• This total includes 3,000,000 shares of Common Stock issuable upon the exercise of outstanding Warrants.
• The beneficial ownership represents 52.8% of the Issuer's Common Stock, calculated based on 5,185,780 shares outstanding as of March 31, 2025, and assuming the exercise of all outstanding Warrants for cash.
• No other transactions in the Common Stock were effected by the Reporting Persons in the past 60 days, apart from the described conversion.

Sentiment

Score: 6

Explanation: The conversion of preferred stock to common stock by a major shareholder, increasing their stake to over 50%, can be viewed positively as a sign of commitment. However, it also introduces potential dilution for other common shareholders and concentrates control, leading to a neutral-to-slightly positive sentiment.

Positives

• The increased commitment and significant stake (over 50%) by a major shareholder (Elray Resources, Inc. and Anthony Brian Goodman) could signal confidence in the company's future.
• The conversion of preferred stock into common stock simplifies the capital structure by reducing preferred share obligations.

Negatives

• The conversion of preferred stock into common stock increases the number of outstanding common shares, potentially leading to dilution for existing common shareholders.

Risks

• Potential dilution for existing common shareholders due to the conversion of preferred stock into common shares.
• The significant concentration of ownership (52.8%) by the reporting persons could impact corporate governance and control.

Future Outlook

The document does not provide explicit forward-looking statements or guidance regarding the company's future operations or financial performance, focusing solely on changes in beneficial ownership.

Industry Context

This filing is a standard disclosure of a change in beneficial ownership by a significant shareholder. It reflects an internal capital structure adjustment (preferred to common conversion) rather than a broader industry trend. The increased stake by a major holder could be seen as a vote of confidence in the biotech/life sciences sector, but the document itself does not provide industry-specific analysis.

Comparison to Industry Standards

• This Schedule 13D/A filing primarily details a change in beneficial ownership and capital structure for 180 Life Sciences Corp.
• As such, it does not contain information that allows for direct comparison to specific comparable companies, projects, or results in terms of operational performance or financial benchmarks.
• The conversion of preferred stock to common stock is a common corporate finance mechanism, but its specific implications depend on the terms of the preferred stock and the company's overall financial health, which are not detailed here for comparative purposes.

Related Party Transactions

• The conversion of Series B Convertible Preferred Stock by Elray Resources, Inc., where Anthony Brian Goodman is CEO and also a reporting person, constitutes a related party transaction as it involves entities and individuals with shared control and interests.

Stakeholder Impact

• Shareholders: Existing common shareholders may experience dilution due to the increase in outstanding common shares. The increased beneficial ownership by the reporting persons (over 50%) could impact voting power and corporate control dynamics.
• Creditors: The conversion of preferred stock to common stock removes a preferred equity obligation, which could be viewed positively by creditors as it simplifies the capital structure and reduces potential fixed dividend payments, though the document does not detail such payments.

Next Steps

• The document does not explicitly mention future actions, events, or milestones for the company or the reporting persons beyond the completed conversion.

Key Dates

Recommendation

Keywords

180 Life Sciences Corp., Elray Resources Inc., Anthony Brian Goodman, Schedule 13D/A, beneficial ownership, preferred stock conversion, common stock, warrants, shareholding, SEC filing, corporate governance, dilution